openPR Logo
Press release

Cancer Vaccines Market - Industrial applications witness fastest growth up to 2025

10-03-2017 12:53 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Cancer Vaccines Market

Cancer Vaccines Market

Vaccines are medicines that stimulate the immune system of the body to protect against foreign substances. The stimulated immune system destroys foreign bodies and remembers it. Vaccines work on this principle of memorizing foreign particle and prevent infection likely to be caused by this foreign particle when it invades again. Cancer vaccines are medicines categorized as biological response modifiers. These modifiers work by stimulating the immune system to fight against disease. Broadly, cancer vaccines are of two types: prevention vaccines and treatment vaccines. Preventive vaccines are used in healthy people to prevent cancer. Treatment vaccines are used in cancer patients to strengthen their natural immune response to fight the disease. Treatment vaccine is a type of immunotherapy. Preventive vaccines are available in the U.S. for human papillomavirus (HPV) and hepatitis B virus. Treatment vaccine is available for metastatic prostate cancer. Cancer preventive vaccines are more like traditional vaccines that recognize the foreign particle and strengthen the immune system against it. Preventive vaccines function by targeting viruses including those producing cancer and activate the immune system against those viruses by producing antibodies. Furthermore, cancer treatment vaccines boost body’s natural immune system to fight against cancer cells. Cancer treatment vaccines are provided to destroy cancer cells left in the body following other treatments, stop further spreading of cancer, and prevent cancer from recurring. Cancer vaccines can be administered intravenously in children as well as adults.

Browse Full Report With ToC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=25292

The World Health Organization reported around 14 million cases of cancer and 8.2 million cancer deaths in 2012. The most common forms among these were lung, colorectal, prostate, cervical, and breast cancers. Hence, demand for vaccines to prevent and treat cancers is high.

Many clinical trials are undergoing by NCI- supported cancer prevention or treatment for different types of cancer using vaccines. Increasing cancer patients, technological advancements, drug development in the field of cancer, government support, rising geriatric population, increasing health care services and expenditure, rising awareness in the incidences of cancer, and available therapies are the factors driving the cancer vaccines market. Low availability of cancer vaccines in remote areas and the need of cold storage and transportation are the factors hampering the growth of the cancer vaccines market.

The global cancer vaccines market has been segmented based on type of vaccine, application of vaccine, end-user, and region. In terms of type of vaccine, the market has been categorized into antigen vaccines, anti-idiotype vaccines, dendritic cell vaccines, whole cell vaccines, and DNA vaccines. Based on application of vaccines, the market has been segmented into preventive (or prophylactic) vaccines and treatment vaccines. Preventive vaccines approved in the U.S. are HPV and hepatitis B vaccines. Treatment vaccines can be of two types: autologous cancer vaccines (derived from oneself) and allogenic cancer vaccines (made from non-cancer cells of one’s own body). In terms of end-user, the cancer vaccines market has been divided into adults and children.

Fill the form for an exclusive sample of this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25292

Geographically, the cancer vaccines market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the market owing to major market share of the U.S. However, the market in Asia Pacific is expected to expand at the highest CAGR during the forecast period due to rising government initiatives, increased focus of players on the vaccine technology market in India, and rising immunization initiatives by the World Health Organization and GAVI.

The global cancer vaccines market is dominated by key players such as AstraZeneca plc, Prima Sanofi, BioMed, GlaxoSmithKline, Merck, Aduro BioTech, OncoThyreon, and Oxford BioMedica.

About Us:-

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us:-

Transparency Market Research

90 State Street, Suite 700, Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Visit Blog: http://marketresearchreports2017.blogspot.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Vaccines Market - Industrial applications witness fastest growth up to 2025 here

News-ID: 752283 • Views: 351

More Releases from Transparency Market Research - Pharmaceutical

Antithrombin Market Estimated to Flourish by 2025
As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016. The global Antithrombin market is consolidated in nature with a few small-scale vendors that operate in regional markets and
Bipolar Disorder (BPD) Market - Global Industry Growth and Forecast 2017 - 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
Otitis Externa Treatment Market - Market Future Growth Opportunities | 2024
Otitis externa causes inflammation of the external ear canal, which is a tube between ear and eardrum. The inflammation is caused due to infection in the ear canal which can be bacterial or fungal origin. Otitis externa is characterized by pain, tenderness, redness, and swelling of the external ear canal. Otitis externa is generally cured within a week, but sometimes it persists for three or more than three months. The
Herpes Zoster (Shingles) Market - Market Future Growth Opportunities | 2024
Herpes Zoster also known as zoster or shingles is a painful contagious viral disease which is characterized by blisters in limited area and painful skin rashes. These blisters full of liquid and pus appear on either side of the body or face, left or right in a single stripe. This disease is caused by varicella zoster virus which develops short lived or acute illness named as chickenpox that is usually

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and